|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Chronic kidney disease stage 2 | 11-Mar-2021 | active |
| Microalbuminuria due to type 2 diabetes mellitus | 11-Mar-2021 | active |
| Disorder of kidney due to diabetes mellitus | 01-Jan-2009 | active |
| Chronic kidney disease stage 1 | 01-Jan-2009 | active |
| Hyperlipidemia | 20-Sep-1990 | active |
| Essential hypertension | 05-Aug-1982 | active |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2025-07-10 | - | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
| Lisinopril 10 mg oral tablet | 2025-07-10 | - | 1 tablet (10 mg) by mouth once daily | Essential hypertension (disorder) |
| Simvastatin 10 mg oral tablet | 2025-04-04 | - | 1 tablet (10 mg) by mouth once daily | Hyperlipidemia |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 05-Dec-2024 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 19-Dec-2019 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Depression screening | 19-Dec-2024 | - |
| Medication reconciliation | 19-Dec-2024 | - |
| Assessment of health and social care needs | 19-Dec-2024 | - |
| Depression screening using Patient Health Questionnaire Two-Item score (procedure) | 19-Dec-2024 | - |
| Assessment using Morse Fall Scale | 05-Dec-2024 | - |
| Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) | 05-Dec-2024 | - |
| Assessment of substance use | 05-Dec-2024 | - |
| Suture open wound | 25-Apr-2019 | Facial laceration |
| Referral to home health care service | 10-Mar-2016 | - |
Allergies and Intolerances
| Allergy/Intolerance | Onset Date | Status | Type | Reaction |
|---|---|---|---|---|
| ? | active | ? |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Hyperlipidemia clinical management plan | 11-Oct-1990 | Hyperlipidemia |
|
||
| Lifestyle education regarding hypertension | 05-Aug-1982 | Essential hypertension (disorder) |
|
||
| Immunization Recommendation | Due Date | Reason |
| Vaccine product containing only Influenza virus antigen (medicinal product) | 01-Oct-2025 | Annual seasonal influenza vaccination |
Vital Signs
| Vital Signs | 2025-07-10 | 2025-04-03 |
|---|---|---|
| Body Height | 154.6 cm | 154.6 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 {score} | 4 {score} |
| Body Weight | 72.5 kg | 72.5 kg |
| Body mass index (BMI) [Ratio] | 30.3 kg/m2 | 30.3 kg/m2 |
| Diastolic Blood Pressure | 70 mm[Hg] | 68 mm[Hg] |
| Systolic Blood Pressure | 113 mm[Hg] | 116 mm[Hg] |
| Heart rate | 77 /min | 97 /min |
| Respiratory rate | 13 /min | 15 /min |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 10-JUL-2025 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Serum or Plasma | 76.4 | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Serum or Plasma | 16.7 | 7 - 50 | mg/dL |
| Creatinine [Mass/volume] in Serum or Plasma | 2.1 H | 0.6 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Serum or Plasma | 9.5 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Serum or Plasma | 143.6 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Serum or Plasma | 4.1 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Serum or Plasma | 102.5 | 98 - 108 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Serum or Plasma | 21.0 L | 22 - 32 | mmol/L |
| Appearance of Urine | Cloudy urine | ||
| Odor of Urine | Urine smell ammoniacal | ||
| Clarity of Urine | Translucent | ||
| Color of Urine | Brown color | ||
| Glucose [Mass/volume] in Urine by Test strip | 1.8 H | 0.8 - 0 | mg/dL |
| Glucose [Presence] in Urine by Test strip | ++ | ||
| Bilirubin.total [Mass/volume] in Urine by Test strip | 0.8 | 0 - 1 | mg/dL |
| Bilirubin.total [Presence] in Urine by Test strip | Finding of bilirubin in urine | ||
| Ketones [Mass/volume] in Urine by Test strip | 12.0 | 0 - 20 | mg/dL |
| Ketones [Presence] in Urine by Test strip | Urine ketone test = + | ||
| Specific gravity of Urine by Test strip | 1.0 L | 1.01 - 1.03 | {nominal} |
| pH of Urine by Test strip | 6.0 | 4.6 - 7 | pH |
| Protein [Mass/volume] in Urine by Test strip | 223.4 H | 0 - 15 | mg/dL |
| Protein [Presence] in Urine by Test strip | Urine protein test = ++ | ||
| Nitrite [Presence] in Urine by Test strip | Urine nitrite negative | ||
| Hemoglobin [Presence] in Urine by Test strip | Urine blood test = negative | ||
| Leukocyte esterase [Presence] in Urine by Test strip | Urine leukocyte test negative |